Find a Clinical Trial

Find a clinical trial underway at the OSUCCC – James.

Search by Keyword

(i.e. John Smith, 197102, Phase 3)

Showing 1-10 of 14

Filtered By: CLL

Open To Accrual

OSU-24190: JCAR017 Subjects Relapsed or Refractory CLL or Small Lymphocytic Lymphoma

Protocol NumberOSU-24190

Open To Accrual

Study of Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Obinutuzumab in Participants With Chronic Lymphocytic Leukemia (CLL)

Protocol NumberOSU-23378

Open To Accrual

Study of SGR-1505 in Mature B-Cell Neoplasms

Protocol NumberOSU-22359

Open To Accrual

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

Protocol NumberOSU-21023

Open To Accrual

A Study of Zilovertamab Vedotin (MK-2140) as Monotherapy and in Combination in Participants With Aggressive and Indolent B-cell Malignancies (MK-2140-006)

Protocol NumberOSU-22080

Open To Accrual

Pirtobrutinib (LOXO-305) and Venetoclax for the Treatment of Patients With CLL or SLL Resistant to Covalent BTKi

Protocol NumberOSU-22172

Open To Accrual

Venetoclax for the Treatment of Patients With Relapsed Hairy Cell Leukemia

Protocol NumberOSU-24174

Open To Accrual

A Ph 2 Study of Glofitamab Alone or in Combination With Polatuzumab Vedotin or Atezolizumab in Richter's Transformation

Protocol NumberOSU-24004

Open To Accrual

Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Protocol NumberOSU-22304

Open To Accrual

Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

Protocol NumberOSU-22157